Search

everythinglearnresearchcommunity

for

Search:↓

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Certain drugs that block specific enzymes can help treat prostate diseases.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Hedgehog pathway inhibitors could be effective in treating melanoma.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Certain substances can strongly inhibit DNA synthesis in hair cells.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Pantethine may boost the immune system's ability to fight sarcoma.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Aptamers can improve wound healing and promote hair growth.

Boosting certain cell signals can prevent hair loss from cancer treatments.

Erlotinib can cause hair loss and texture changes.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

The plant hormone auxin activates the TOR pathway, affecting gene expression related to growth and cell size.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.